Simple Summary This review analyses the occurrence and clinical characteristics of
autoimmune cytopenias and other autoimmune diseases in various lymphoid and myeloid …

Immune checkpoint inhibitors (ICIs) have revolutionized cancer immunotherapy, yielding
significant antitumor responses across multiple cancer types. Combination ICI therapy with …

Background Immune checkpoints inhibitors have transformed the prognosis of advanced
melanoma but are associated with immune-related adverse events (irAEs). We evaluated …

Background Immune checkpoint inhibitors, approved for the treatment of various types of
cancer, are known to cause a unique spectrum of side effects, including acute kidney injury …

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, improving
outcomes in patients with advanced malignancies. The use of ICIs in clinical practice, and …

Summary CTLA‐4 and PD‐1 play a key role in tumor‐induced downregulation of
lymphocytic immune responses. Immune checkpoint inhibitors have been shown to alter the …

Objective To evaluate prevalence and clinical features of immune-related adverse events
(irAEs) to immune checkpoint inhibitors (ICIs) in accordance with the gender of treated …

Immune checkpoint inhibitors (ICIs) targeting programmed cell death-1 (PD-1 or CD279)
have noticeably improved the treatment landscape of advanced cancer patients. Nivolumab …

Simple Summary Immune-oncology has revolutionized the natural history of many cancers
in the past decade, becoming a new therapeutic weapon. The identification of immune …

Cisplatin should be administered with diuretics and Magnesium supplementation under
adequate hydration to avoid renal impairment. Patients should be evaluated for eGFR …